Difficulty: Medium
Average Score: 75%
Practice
All of the following effects of ACE inhibitors may be useful in treating heart failure EXCEPT:
Correct answer
B
Rationale
In the context of advanced pharmacology across the lifespan, understanding the effects of ACE inhibitors in treating heart failure is crucial. The correct answer is B) They increase circulating catecholamine levels, which is not a beneficial effect in heart failure management. Elevated catecholamines can exacerbate heart failure symptoms by increasing myocardial workload and oxygen demand.
A) ACE inhibitors decrease afterload by dilating blood vessels, reducing the heart's workload, and improving cardiac output, making this effect beneficial in heart failure treatment.
C) ACE inhibitors reduce reactive myocardial hypertrophy by blocking the harmful effects of angiotensin II on cardiac remodeling, which is beneficial in preventing further deterioration of heart function in heart failure patients.
D) ACE inhibitors do not increase myocardial beta-1 adrenergic receptor density. Instead, they may downregulate these receptors over time, leading to improved outcomes in heart failure by reducing the heart's sensitivity to catecholamines.
Educationally, understanding the specific effects of medications used in heart failure management is vital for healthcare professionals to make informed decisions regarding patient care. By grasping the mechanisms of action and potential outcomes of ACE inhibitors, clinicians can optimize treatment strategies and improve patient outcomes in individuals across the lifespan with heart failure.
A) ACE inhibitors decrease afterload by dilating blood vessels, reducing the heart's workload, and improving cardiac output, making this effect beneficial in heart failure treatment.
C) ACE inhibitors reduce reactive myocardial hypertrophy by blocking the harmful effects of angiotensin II on cardiac remodeling, which is beneficial in preventing further deterioration of heart function in heart failure patients.
D) ACE inhibitors do not increase myocardial beta-1 adrenergic receptor density. Instead, they may downregulate these receptors over time, leading to improved outcomes in heart failure by reducing the heart's sensitivity to catecholamines.
Educationally, understanding the specific effects of medications used in heart failure management is vital for healthcare professionals to make informed decisions regarding patient care. By grasping the mechanisms of action and potential outcomes of ACE inhibitors, clinicians can optimize treatment strategies and improve patient outcomes in individuals across the lifespan with heart failure.